icon-avatar
Economía

COMUNICADO: LAP-BAND(TM) es el primer dispositivo de intervención de la obesidad en Europa (y 2)

    [vii] Dixon, JB, O'Brien, PE et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. Vol 299 (3) January 2008

    [viii] Chapman A, Game P, OBrien P, Maddern G, Kiroff G, Foster B, Ham J. Executive summary: Laparoscopic adjustable gastric banding for the treatment of obesity: Update and re-appraisal. Australian Safety and Efficacy Register of New Interventional Procedures-Surgical (ASERNIP-S) Report No. 31, Second Edition. Adelaide, South Australia: ASERNIP-S, June 2002.

    [ix] Parikh MS, Shen R, Weiner M, Siegel N, Ren CJ. Laparoscopic bariatricsurgery in super-obese patients (BMI>50) is safe and effective: a review of 332 patients. Obes Surg. 2005 Jun-Jul;15(6):858-63

    [x] Chapman AE, Kiroff G, Game P, Foster B, O'Brien P, Ham J, Maddern GJ. Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surgery 2004;135:326-351

    Contactos de medios: Janet Kettels, Allergan Communications, Móvil: +44-7738-506-476, E-mail : kettels_janet@allergan.com. Katy Sparks, Just Health PR, +44-(0)20-8877-8420, katy@justhealthpr.com

    Relacionados

    WhatsAppFacebookFacebookTwitterTwitterLinkedinLinkedinBeloudBeloudBluesky